- Home
- LFST vs VKTX Comparison
LFST vs VKTX Comparison
Compare LFST & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LFST | VKTX |
|---|---|---|
| Founded | 2015 | 2012 |
| Country | United States | United States |
| Employees | 8542 | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.0B |
| IPO Year | 2021 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LFST | VKTX |
|---|---|---|
| Price | $12.67 | $30.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | $9.83 | ★ $95.86 |
| AVG Volume (30 Days) | ★ 4.5M | 1.8M |
| Earning Date | 05-07-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,424,285,000.00 | N/A |
| Revenue This Year | $17.18 | N/A |
| Revenue Next Year | $14.02 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 13.85 | N/A |
| 52 Week Low | $4.78 | $24.78 |
| 52 Week High | $14.15 | $43.15 |
Technical Indicators
Market Signals| Indicator | LFST | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 53.90 | 41.69 |
| Support Level | $11.92 | $29.32 |
| Resistance Level | $12.97 | $34.00 |
| Average True Range (ATR) | 0.51 | 1.42 |
| MACD | -0.09 | -0.32 |
| Stochastic Oscillator | 20.53 | 34.35 |
Price Performance
Historical ComparisonAbout LFST LifeStance Health Group Inc.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.